Ginkgo Bioworks Holdings, Inc. earnings per share and revenue
On 06 de nov. de 2025, DNA reported earnings of -1.45 USD per share (EPS) for Q3 25, missing the estimate of -1.25 USD, resulting in a -15.78% surprise. Revenue reached 38.84 milhão, compared to an expected 39.24 milhão, with a -1.02% difference. The market reacted with a -20.80% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Ginkgo Bioworks Holdings, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ginkgo Bioworks Holdings, Inc. reported EPS of -$1.45, missing estimates by -15.78%, and revenue of $38.84M, -1.02% below expectations.
How did the market react to Ginkgo Bioworks Holdings, Inc.'s Q3 2025 earnings?
The stock price moved down -20.8%, changed from $11.30 before the earnings release to $8.95 the day after.
When is Ginkgo Bioworks Holdings, Inc. expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Ginkgo Bioworks Holdings, Inc.'s next earnings report?
Based on --
analistas, Ginkgo Bioworks Holdings, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.